Magnetic resonance elastography

Last updated

Magnetic resonance elastography (MRE) is a form of elastography that specifically leverages MRI to quantify and subsequently map the mechanical properties (elasticity or stiffness) of soft tissue. First developed and described at Mayo Clinic by Muthupillai et al. in 1995, MRE has emerged as a powerful, non-invasive diagnostic tool, namely as an alternative to biopsy and serum tests for staging liver fibrosis. [1] [2] [3] [4] [5]

Contents

Diseased tissue (e.g. a breast tumor) is often stiffer than the surrounding normal (fibroglandular) tissue, [6] providing motivation to assess tissue stiffness. [7] This principle of operation is the basis for the longstanding practice of palpation, which, however, is limited (except at surgery) to superficial organs and pathologies, and by its subjective, qualitative nature, depending on the skill and touch sensitivity of the practitioner. Conventional imaging techniques of CT, MRI, US, and nuclear medicine are unable to offer any insight on the elastic modulus of soft tissue. [2] MRE, as a quantitative method of assessing tissue stiffness, provides reliable insight to visualize a variety of disease processes which affect tissue stiffness in the liver, brain, heart, pancreas, kidney, spleen, breast, uterus, prostate, and skeletal muscle. [2] [3] [8]

MRE is conducted in three steps: first, a mechanical vibrator is used on the surface of the patient's body to generate shear waves that travel into the patient's deeper tissues; second, an MRI acquisition sequence measures the propagation and velocity of the waves; and finally this information is processed by an inversion algorithm to quantitatively infer and map tissue stiffness in 3-D. [2] [3] This stiffness map is called an elastogram, and is the final output of MRE, along with conventional 3-D MRI images as shown on the right. [2]

Mechanics of soft tissue

MRE quantitatively determines the stiffness of biological tissues by measuring its mechanical response to an external stress. [3] Specifically, MRE calculates the shear modulus of a tissue from its shear-wave displacement measurements. [7] The elastic modulus quantifies the stiffness of a material, or how well it resists elastic deformation as a force is applied. For elastic materials, strain is directly proportional to stress within an elastic region. The elastic modulus is seen as the proportionality constant between stress and strain within this region. Unlike purely elastic materials, biological tissues are viscoelastic, meaning that it has characteristics of both elastic solids and viscous liquids. Their mechanical responses depend on the magnitude of the applied stress as well as the strain rate. The stress-strain curve for a viscoelastic material exhibits hysteresis. The area of the hysteresis loop represents the amount of energy lost as heat when a viscoelastic material undergoes an applied stress and is distorted. For these materials, the elastic modulus is complex and can be separated into two components: a storage modulus and a loss modulus. The storage modulus expresses the contribution from elastic solid behavior while the loss modulus expresses the contribution from viscous liquid behavior. Conversely, elastic materials exhibit a pure solid response. When a force is applied, these materials elastically store and release energy, which does not result in energy loss in the form of heat. [9]

Yet, MRE and other elastography imaging techniques typically utilize a mechanical parameter estimation that assumes biological tissues to be linearly elastic and isotropic for simplicity purposes. [10] The effective shear modulus can be expressed with the following equation:

where is the elastic modulus of the material and is the Poisson’s ratio.

The Poisson’s ratio for soft tissues is approximated to equal 0.5, resulting in the ratio between the elastic modulus and shear modulus to equal 3. [11] This relationship can be used to estimate the stiffness of biological tissues based on the calculated shear modulus from shear-wave propagation measurements. A driver system produces and transmits acoustic waves set at a specific frequency (50–500 Hz) to the tissue sample. At these frequencies, the velocity of shear waves can be about 1–10 m/s. [12] [13] The effective shear modulus can be calculated from the shear wave velocity with the following: [14]

where is the tissue density and is the shear wave velocity.

Recent studies have been focused on incorporating mechanical parameter estimations into post-processing inverse algorithms that account for the complex viscoelastic behavior of soft tissues. Creating new parameters could potentially increase the specificity of MRE measurements and diagnostic testing. [15] [16]

Applications

Liver

MR elastography for detection of liver fibrosis in two patients. The left column shows the anatomy, with the liver outlined. The middle row shows images of propagating shear waves in the liver, captured with the MRE technique. The right column shows elastograms computed from the wave images, with tissue stiffness depicted with on color scale. In the top row, the mean liver stiffness is 1.8 kPa, in the normal range. In the lower row, the patient has a mean liver stiffness of 5.7 kPa, indicating the presence of advanced liver fibrosis (cirrhosis). LiverMRE wiki final.tif
MR elastography for detection of liver fibrosis in two patients.  The left column shows the anatomy, with the liver outlined. The middle row shows images of propagating shear waves in the liver, captured with the MRE technique. The right column shows elastograms computed from the wave images, with tissue stiffness depicted with on color scale.  In the top row, the mean liver stiffness is 1.8 kPa, in the normal range.  In the lower row, the patient has a mean liver stiffness of 5.7 kPa, indicating the presence of advanced liver fibrosis (cirrhosis).

Liver fibrosis is a common condition arising in many liver diseases. Progression of fibrosis can lead to cirrhosis and end-stage liver disease. MRE-based measurement of liver stiffness has emerged as the most accurate non-invasive technique for detecting and staging liver fibrosis. MRE provides quantitative maps of tissue stiffness over large regions of the liver. Abnormally increased liver stiffness is a direct consequence of liver fibrosis. The diagnostic performance of MRE in assessing liver fibrosis has been established in multiple studies. [17] [18] [16] [19]

Liver MRE examinations are performed in MRI systems that have been equipped for the technique.   Patients should fast for  3 to 4 hours prior to their MRE exam to allow for the most accurate measurement of liver stiffness. [20] [21] [22] Patients lie supine in the MRI scanner for the examination.  A special device is placed on the right side of the chest wall over the liver to apply gentle vibration which generates propagating shear waves in the liver.   Imaging is for MRE is very quick, with data acquired in a series of  1-4 periods of breath-holding, each lasting 15–20 seconds.   

A standardized approach for performing and analyzing liver MRE exams has been documented by the RSNA Quantitative Imaging Biomarkers Alliance. [23] The technical success rate of Liver MRE is very high (95-100%) [24] [25] [26]

Brain

Magnetic resonance elastography
Murphy 2013 brain MRE with wave image.png
Magnetic resonance elastography of the brain. A T1 weighted anatomical image is shown in the top-left, and the corresponding T2 weighted image from the MRE data is shown in the bottom-left. The wave image used to make the elastogram is shown in the top-right, and the resulting elastogram is in the bottom-right.
Purposemeasures the mechanical properties of soft tissues

MRE of the brain [27] was first presented in the early 2000s. [28] [29] Elastogram measures have been correlated with memory tasks, [30] fitness measures, [31] and progression of various neurodegenerative conditions. [27] For example, regional and global decreases in brain viscoelasticity have been observed in Alzheimer’s disease [32] [33] and multiple sclerosis. [34] [35] It has been found that as the brain ages, it loses its viscoelastic integrity due to degeneration of neurons and oligodendrocytes. [36] [37] A recent study looked into both the isotropic and anisotropic stiffness in brain and found a correlation between the two and with age, particularly in gray matter. [38]

MRE may also have applications for understanding the adolescent brain. Recently, it was found that adolescents have regional differences in brain viscoelasticity relative to adults. [39] [40]

MRE has also been applied to functional neuroimaging. Whereas functional magnetic resonance imaging (fMRI) infers brain activity by detecting relatively slow changes in blood flow, functional MRE is capable of detecting neuromechanical changes in the brain related to neuronal activity occurring on the 100-millisecond scale. [41]

Kidney

MRE has also been applied to investigate the biomechanical properties of the kidney. The feasibility of clinical renal MRE was first reported in 2011 for healthy volunteers [42] and in 2012 for renal transplant patients. [43] Renal MRE is more challenging than MRE of larger organs such as the brain or liver due to fine mechanical features in the renal cortex and medulla as well as the acoustically shielded position of the kidneys within the abdominal cavity. To overcome these challenges, researchers have been looking at different passive drivers and imaging techniques to best deliver shear waves to the kidneys. [44] [45] [46] [47] [48] Studies investigating renal diseases such as renal allograft dysfunction, [49] [50] [51] [52] lupus nephritis, [53] immunoglobulin A nephropathy (IgAN), [54] diabetic nephrology, [55] renal tumors [56] and chronic kidney disease [57] demonstrate that kidney stiffness is sensitive to kidney function [58] [59] and renal perfusion. [58] [60]

MR elastography (Tomoelastography) of (a) the kidney, (b) the prostate, and (c) the pancreas. The T2 weighted magnitude images from tomoelastography are shown in the left column while the corresponding elastograms are shown on the right. In (b), images from a healthy volunteer (top row) and a patient with prostate cancer in transition zone (bottom row, lesion indicated by arrow) are shown. Similarly, (c) shows images from a healthy volunteer (top row) and a patient with pancreatic ductal adenocarcinoma (PDAC) (bottom row, PDAC and pancreatic parenchyma are indicated by filled and empty arrows, respectively). MRE-of Kidney Prostate and Pancreas.tif
MR elastography (Tomoelastography) of (a) the kidney, (b) the prostate, and (c) the pancreas. The T2 weighted magnitude images from tomoelastography are shown in the left column while the corresponding elastograms are shown on the right. In (b), images from a healthy volunteer (top row) and a patient with prostate cancer in transition zone (bottom row, lesion indicated by arrow) are shown. Similarly, (c) shows images from a healthy volunteer (top row) and a patient with pancreatic ductal adenocarcinoma (PDAC) (bottom row, PDAC and pancreatic parenchyma are indicated by filled and empty arrows, respectively).

Prostate

The prostate can also be examined by MRE, in particular for the detection and diagnosis of prostate cancer. [61] To ensure good shear wave penetration in the prostate gland, different actuator systems were designed and evaluated. [62] [63] Preliminary results in patients with prostate cancer showed that changes in stiffness allowed differentiation of cancerous tissue from normal tissue. [64] Magnetic Resonance Elastography has been successfully used in patients with prostate cancer showing high specificity and sensitivity in differentiating prostate cancer from benign prostatic diseases [65] [66] (see figure on right (b)). Even higher specificity of 95% for prostate cancer was achieved when Magnetic Resonance Elastography was combined with systematic image interpretation using PI-RADS (version 2.1). [66] [67]

Pancreas

The pancreas is one of the softest tissues in the abdomen. Given that pancreatic diseases including pancreatitis and pancreatic cancer significantly increase stiffness, MRE is a promising tool for diagnosing benign and malignant conditions of the pancreas. Abnormally high pancreatic stiffness was detected by MRE in patients with both acute and chronic pancreatitis. [68] Pancreatic stiffness was also used to distinguish pancreatic malignancy from benign masses [69] and to predict the occurrence of pancreatic fistula after pancreaticoenteric anastomosis. [70] Quantification of the volume of pancreatic tumors based on tomoelastographic measurement of stiffness was found to be excellently correlated with tumor volumes estimated by contrast-enhanced computed tomography. [71] In patients with pancreatic ductal adenocarcinoma stiffness was found to be elevated in the tumor as well as in pancreatic parenchyma distal to the tumor, suggesting heterogeneous pancreatic involvement [72] (figure on right (c)).

See also

Related Research Articles

<span class="mw-page-title-main">Magnetic resonance imaging</span> Medical imaging technique

Magnetic resonance imaging (MRI) is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes of the body. MRI scanners use strong magnetic fields, magnetic field gradients, and radio waves to generate images of the organs in the body. MRI does not involve X-rays or the use of ionizing radiation, which distinguishes it from computed tomography (CT) and positron emission tomography (PET) scans. MRI is a medical application of nuclear magnetic resonance (NMR) which can also be used for imaging in other NMR applications, such as NMR spectroscopy.

<span class="mw-page-title-main">Medical imaging</span> Technique and process of creating visual representations of the interior of a body

Medical imaging is the technique and process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology). Medical imaging seeks to reveal internal structures hidden by the skin and bones, as well as to diagnose and treat disease. Medical imaging also establishes a database of normal anatomy and physiology to make it possible to identify abnormalities. Although imaging of removed organs and tissues can be performed for medical reasons, such procedures are usually considered part of pathology instead of medical imaging.

<span class="mw-page-title-main">Elastography</span> Any of several imaging modalities that map degrees of soft-tissue elasticity and stiffness

Elastography is any of a class of medical imaging modalities that map the elastic properties and stiffness of soft tissue. The main idea is that whether the tissue is hard or soft will give diagnostic information about the presence or status of disease. For example, cancerous tumours will often be harder than the surrounding tissue, and diseased livers are stiffer than healthy ones.

<span class="mw-page-title-main">Steatosis</span> Medical condition

Steatosis, also called fatty change, is abnormal retention of fat (lipids) within a cell or organ. Steatosis most often affects the liver – the primary organ of lipid metabolism – where the condition is commonly referred to as fatty liver disease. Steatosis can also occur in other organs, including the kidneys, heart, and muscle. When the term is not further specified, it is assumed to refer to the liver.

<span class="mw-page-title-main">Fatty liver disease</span> Medical condition related to obesity

Steatotic liver disease (SLD) a.k.a. fatty liver disease (FLD) or hepatic steatosis, is a condition where excess fat builds up in the liver. Often there are no or few symptoms. Occasionally there may be tiredness or pain in the upper right side of the abdomen. Complications may include cirrhosis, liver cancer, and esophageal varices.

Durotaxis is a form of cell migration in which cells are guided by rigidity gradients, which arise from differential structural properties of the extracellular matrix (ECM). Most normal cells migrate up rigidity gradients.

<span class="mw-page-title-main">Liver biopsy</span>

Liver biopsy is the biopsy from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.

<span class="mw-page-title-main">Non-alcoholic fatty liver disease</span> Excessive fat buildup in the liver not caused by alcohol use

Metabolic (dysfunction) associated fatty liver disease (MAFLD) was previously known as non-alcoholic fatty liver disease (NAFLD) until renamed in 2023 by a global consensus panel composed mostly of hepatology researchers and clinicians. The term metabolic dysfunction-associated steatotic liver disease (MASLD) is also used. MAFLD is excessive fat build-up in the liver without another clear cause such as alcohol use. There are two types; non-alcoholic fatty liver (NAFL) and metabolic dysfunction–associated steatohepatitis, with the latter also including liver inflammation. NAFL is less dangerous than MASH and usually does not progress towards it. When NAFL does progress to NASH, it may eventually lead to complications such as cirrhosis, liver cancer, liver failure, or cardiovascular disease.

<span class="mw-page-title-main">Gadodiamide</span> Chemical compound

Gadodiamide, sold under the brand name Omniscan, is a gadolinium-based MRI contrast agent (GBCA), used in magnetic resonance imaging (MRI) procedures to assist in the visualization of blood vessels.

Nephrogenic systemic fibrosis is a rare syndrome that involves fibrosis of the skin, joints, eyes, and internal organs. NSF is caused by exposure to gadolinium in gadolinium-based MRI contrast agents (GBCAs) in patients with impaired kidney function. Epidemiological studies suggest that the incidence of NSF is unrelated to gender or ethnicity and it is not thought to have a genetic basis. After GBCAs were identified as a cause of the disorder in 2006, and screening and prevention measures put in place, it is now considered rare.

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based contrast agents (GBCAs). Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.

<span class="mw-page-title-main">Hemosiderosis</span> Iron metabolism disease

Hemosiderosis is a form of iron overload disorder resulting in the accumulation of hemosiderin.

<span class="mw-page-title-main">Gadoteric acid</span> Chemical compound

Gadoteric acid, sold under the brand name Dotarem among others, is a macrocycle-structured gadolinium-based MRI contrast agent (GBCA). It consists of the organic acid DOTA as a chelating agent, and gadolinium (Gd3+), and is used in form of the meglumine salt (gadoterate meglumine). The paramagnetic property of gadoteric acid reduces the T1 relaxation time (and to some extent the T2 and T2* relaxation times) in MRI, which is the source of its clinical utility. Because it has magnetic properties, gadoteric acid develops a magnetic moment when put under a magnetic field, which increases the signal intensity (brightness) of tissues during MRI imaging.

<span class="mw-page-title-main">Cirrhosis</span> Chronic disease of the liver, characterized by fibrosis

Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, and end-stage liver disease, is the impaired liver function caused by the formation of scar tissue known as fibrosis due to damage caused by liver disease. Damage to the liver leads to repair of liver tissue and subsequent formation of scar tissue. Over time, scar tissue can replace normal functioning tissue, leading to the impaired liver function of cirrhosis. The disease typically develops slowly over months or years. Early symptoms may include tiredness, weakness, loss of appetite, unexplained weight loss, nausea and vomiting, and discomfort in the right upper quadrant of the abdomen. As the disease worsens, symptoms may include itchiness, swelling in the lower legs, fluid build-up in the abdomen, jaundice, bruising easily, and the development of spider-like blood vessels in the skin. The fluid build-up in the abdomen develop spontaneous infections. More serious complications include hepatic encephalopathy, bleeding from dilated veins in the esophagus, stomach, or intestines, and liver cancer.

<span class="mw-page-title-main">Intravoxel incoherent motion</span> Concept and a method initially introduced and developed by Le Bihan et al

Intravoxel incoherent motion (IVIM) imaging is a concept and a method initially introduced and developed by Le Bihan et al. to quantitatively assess all the microscopic translational motions that could contribute to the signal acquired with diffusion MRI. In this model, biological tissue contains two distinct environments: molecular diffusion of water in the tissue, and microcirculation of blood in the capillary network (perfusion). The concept introduced by D. Le Bihan is that water flowing in capillaries mimics a random walk (Fig.1), as long as the assumption that all directions are represented in the capillaries is satisfied.

Irreversible electroporation is a soft tissue ablation technique using short but strong electrical fields to create permanent and hence lethal nanopores in the cell membrane, to disrupt cellular homeostasis. The resulting cell death results from induced apoptosis or necrosis induced by either membrane disruption or secondary breakdown of the membrane due to transmembrane transfer of electrolytes and adenosine triphosphate. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The first generation of IRE for clinical use, in the form of the NanoKnife System, became commercially available for research purposes in 2009, solely for the surgical ablation of soft tissue tumors. Cancerous tissue ablation via IRE appears to show significant cancer specific immunological responses which are currently being evaluated alone and in combination with cancer immunotherapy.

Sodium MRI is a specialised magnetic resonance imaging technique that uses strong magnetic fields, magnetic field gradients, and radio waves to generate images of the distribution of sodium in the body, as opposed to more common forms of MRI that utilise protons present in water (1H-MRI). Like the proton, sodium is naturally abundant in the body, so can be imaged directly without the need for contrast agents or hyperpolarization. Furthermore, sodium ions play a role in important biological processes via their contribution to concentration and electrochemical gradients across cellular membranes, making it of interest as an imaging target in health and disease.

COACH syndrome, also known as Joubert syndrome with hepatic defect, is a rare autosomal recessive genetic disease. The name is an acronym of the defining signs: cerebellar vermis aplasia, oligophrenia, congenital ataxia, coloboma and hepatic fibrosis. The condition is associated with moderate intellectual disability. It falls under the category of a Joubart Syndrome-related disorder (JSRD).

Optical coherence elastography (OCE) is an emerging imaging technique used in biomedical imaging to form pictures of biological tissue in micron and submicron level and maps the biomechanical property of tissue.

<span class="mw-page-title-main">Tomoelastography</span> Medical imaging technique

Tomoelastography is a medical imaging technique that provides quantitative maps of the mechanical properties of biological soft tissues with high spatial resolution. It is an advancement of elastography in that it generates unmasked maps of stiffness and viscosity across the entire field of view that can be captured with a given imaging modality. Medical ultrasound and magnetic resonance imaging (MRI) are the most commonly used imaging modalities for elastography. Classical elastography only measures stiffness in a limited region, such as at a depth of 6 cm in the liver or in a selected liver lobe, and thus cannot provide an overview of the adjacent tissues or organs. Tomoelastography, on the other hand, is a radiological imaging method that allows estimation of quantitative mechanical parameters of all organs and structures in the field of view. Moreover, tomoelastography does not rely on a single, specific imaging modality. While it has been introduced and is mostly performed using magnetic resonance elastography (MRE), tomoelastography can be extended to other imaging techniques as well.

References

  1. ↑ Hirsch, Sebastian; Braun, Jürgen; Sack, Ingolf (2016). Magnetic Resonance Elastography | Wiley Online Books. doi:10.1002/9783527696017. ISBN   9783527696017.
  2. 1 2 3 4 5 Mariappan YK, Glaser KJ, Ehman RL (2010). "Magnetic resonance elastography: a review". Clin Anat. 23 (5): 497–511. doi:10.1002/ca.21006. PMC   3066083 . PMID   20544947.
  3. 1 2 3 4 Glaser KJ, Manduca A, Ehman RL (14 September 2012). "Review of MR elastography applications and recent developments". J Magn Reson Imaging. 36 (4): 757–74. doi:10.1002/jmri.23597. PMC   3462370 . PMID   22987755.
  4. ↑ Chen J, Yin M, Glaser KJ, Talwalkar JA, Ehman RL (2013). "MR Elastography of Liver Disease: State of the Art". Appl Radiol. 42 (4): 5–12. doi:10.37549/AR1982. PMC   4564016 . PMID   26366024.
  5. ↑ Ingolf Sack: Magnetic resonance elastography from fundamental soft-tissue mechanics to diagnostic imaging. In: Nature Reviews Physics. 5, 2023, S. 25, doi : 10.1038/s42254-022-00543-2.
  6. ↑ Pepin KM, Ehman RL, McGee KP (2015). "Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications". Prog Nucl Magn Reson Spectrosc. 90–91: 32–48. doi:10.1016/j.pnmrs.2015.06.001. PMC   4660259 . PMID   26592944.
  7. 1 2 Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL (September 1995). "Magnetic resonance elastography by direct visualization of propagating acoustic strain waves". Science. 269 (5232): 1854–7. Bibcode:1995Sci...269.1854M. doi:10.1126/science.7569924. PMID   7569924.
  8. ↑ Wang, Jin; Deng, Ying; Jondal, Danielle; Woodrum, David M.; Shi, Yu; Yin, Meng; Venkatesh, Sudhakar K. (2018). "New and Emerging Applications of Magnetic Resonance Elastography of Other Abdominal Organs". Topics in Magnetic Resonance Imaging. 27 (5): 335–352. doi:10.1097/RMR.0000000000000182. ISSN   0899-3459. PMC   7042709 . PMID   30289829.
  9. ↑ Wineman A (2009). "Nonlinear Viscoelastic Solids—A Review". Mathematics and Mechanics of Solids. 14 (3): 300–366. doi:10.1177/1081286509103660. ISSN   1081-2865. S2CID   121161691.
  10. ↑ Mariappan YK, Glaser KJ, Ehman RL (July 2010). "Magnetic resonance elastography: a review". Clinical Anatomy. 23 (5): 497–511. doi:10.1002/ca.21006. PMC   3066083 . PMID   20544947.
  11. ↑ Low G, Kruse SA, Lomas DJ (January 2016). "General review of magnetic resonance elastography". World Journal of Radiology. 8 (1): 59–72. doi: 10.4329/wjr.v8.i1.59 . PMC   4731349 . PMID   26834944.
  12. ↑ Sarvazyan AP, Skovoroda AR, Emelianov SY, Fowlkes JB, Pipe JG, Adler RS, et al. (1995). "Biophysical Bases of Elasticity Imaging". Acoustical Imaging. Vol. 21. Springer US. pp. 223–240. doi:10.1007/978-1-4615-1943-0_23. ISBN   978-1-4613-5797-1.
  13. ↑ Cameron J (1991). "Physical Properties of Tissue. A Comprehensive Reference Book, edited by Francis A. Duck". Medical Physics. 18 (4): 834. Bibcode:1991MedPh..18..834C. doi: 10.1118/1.596734 .
  14. ↑ Wells PN, Liang HD (November 2011). "Medical ultrasound: imaging of soft tissue strain and elasticity". Journal of the Royal Society, Interface. 8 (64): 1521–49. doi:10.1016/S1361-8415(00)00039-6. PMC   3177611 . PMID   21680780.
  15. ↑ Sinkus R, Tanter M, Catheline S, Lorenzen J, Kuhl C, Sondermann E, Fink M (February 2005). "Imaging anisotropic and viscous properties of breast tissue by magnetic resonance-elastography". Magnetic Resonance in Medicine. 53 (2): 372–87. doi: 10.1002/mrm.20355 . PMID   15678538.
  16. 1 2 Asbach P, Klatt D, Schlosser B, Biermer M, Muche M, Rieger A, et al. (October 2010). "Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography". Radiology. 257 (1): 80–6. doi:10.1148/radiol.10092489. PMID   20679447.
  17. ↑ Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al. (October 2007). "Assessment of hepatic fibrosis with magnetic resonance elastography". Clinical Gastroenterology and Hepatology. 5 (10): 1207–1213.e2. doi:10.1016/j.cgh.2007.06.012. PMC   2276978 . PMID   17916548.
  18. ↑ Huwart L, Sempoux C, Vicaut E, Salameh N, Annet L, Danse E, et al. (July 2008). "Magnetic resonance elastography for the noninvasive staging of liver fibrosis". Gastroenterology. 135 (1): 32–40. doi: 10.1053/j.gastro.2008.03.076 . PMID   18471441.
  19. ↑ Venkatesh SK, Yin M, Ehman RL (March 2013). "Magnetic resonance elastography of liver: technique, analysis, and clinical applications". Journal of Magnetic Resonance Imaging. 37 (3): 544–55. doi:10.1002/jmri.23731. PMC   3579218 . PMID   23423795.
  20. ↑ Jajamovich, Guido H.; Dyvorne, Hadrien; Donnerhack, Claudia; Taouli, Bachir (2014-05-19). "Quantitative Liver MRI Combining Phase Contrast Imaging, Elastography, and DWI: Assessment of Reproducibility and Postprandial Effect at 3.0 T". PLOS ONE. 9 (5): e97355. Bibcode:2014PLoSO...997355J. doi: 10.1371/journal.pone.0097355 . ISSN   1932-6203. PMC   4026225 . PMID   24840288.
  21. ↑ Obrzut, Marzanna; Atamaniuk, Vitaliy; Chen, Jun; Obrzut, Bogdan; Ehman, Richard L.; Cholewa, Marian; Palusińska, Agnieszka; Gutkowski, Krzysztof (2021-10-05). "Postprandial hepatic stiffness changes on magnetic resonance elastography in healthy volunteers". Scientific Reports. 11 (1): 19786. Bibcode:2021NatSR..1119786O. doi:10.1038/s41598-021-99243-7. ISSN   2045-2322. PMC   8492759 . PMID   34611231.
  22. ↑ Yin, Meng; Talwalkar, Jayant A.; Glaser, Kevin J.; Venkatesh, Sudhakar K.; Chen, Jun; Manduca, Armando; Ehman, Richard L. (July 2011). "Dynamic Postprandial Hepatic Stiffness Augmentation Assessed With MR Elastography in Patients With Chronic Liver Disease". AJR. American Journal of Roentgenology. 197 (1): 64–70. doi:10.2214/AJR.10.5989. ISSN   0361-803X. PMC   3151663 . PMID   21701012.
  23. ↑ "Profiles - QIBA Wiki". qibawiki.rsna.org. Retrieved 2023-02-21.
  24. ↑ Singh, Siddharth; Venkatesh, Sudhakar K.; Wang, Zhen; Miller, Frank H.; Motosugi, Utaroh; Low, Russell N.; Hassanein, Tarek; Asbach, Patrick; Godfrey, Edmund M.; Yin, Meng; Chen, Jun; Keaveny, Andrew P.; Bridges, Mellena; Bohte, Anneloes; Murad, Mohammad Hassan (March 2015). "Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data". Clinical Gastroenterology and Hepatology. 13 (3): 440–451.e6. doi:10.1016/j.cgh.2014.09.046. ISSN   1542-3565. PMC   4333001 . PMID   25305349.
  25. ↑ Kennedy, Paul; Wagner, Mathilde; Castéra, Laurent; Hong, Cheng William; Johnson, Curtis L.; Sirlin, Claude B.; Taouli, Bachir (March 2018). "Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions". Radiology. 286 (3): 738–763. doi:10.1148/radiol.2018170601. ISSN   0033-8419. PMC   5831316 . PMID   29461949.
  26. ↑ Joshi, Madalsa; Dillman, Jonathan R.; Towbin, Alexander J.; Serai, Suraj D.; Trout, Andrew T. (June 2017). "MR elastography: high rate of technical success in pediatric and young adult patients". Pediatric Radiology. 47 (7): 838–843. doi:10.1007/s00247-017-3831-z. ISSN   1432-1998. PMID   28367603. S2CID   24875956.
  27. 1 2 Hiscox LV, Johnson CL, Barnhill E, McGarry MD, Huston J, van Beek EJ, Starr JM, Roberts N (December 2016). "Magnetic resonance elastography (MRE) of the human brain: technique, findings and clinical applications" (PDF). Phys Med Biol. 61 (24): R401–R437. Bibcode:2016PMB....61R.401H. doi:10.1088/0031-9155/61/24/R401. PMID   27845941. S2CID   1194782.
  28. ↑ Van Houten EE, Paulsen KD, Miga MI, Kennedy FE, Weaver JB (October 1999). "An overlapping subzone technique for MR-based elastic property reconstruction". Magnetic Resonance in Medicine. 42 (4): 779–86. doi:10.1002/(SICI)1522-2594(199910)42:4<779::AID-MRM21>3.0.CO;2-Z. PMID   10502768. S2CID   13244029.
  29. ↑ Van Houten EE, Miga MI, Weaver JB, Kennedy FE, Paulsen KD (May 2001). "Three-dimensional subzone-based reconstruction algorithm for MR elastography". Magnetic Resonance in Medicine. 45 (5): 827–37. doi: 10.1002/mrm.1111 . PMID   11323809.
  30. ↑ Schwarb H, Johnson CL, McGarry MD, Cohen NJ (May 2016). "Medial temporal lobe viscoelasticity and relational memory performance". NeuroImage. 132: 534–541. doi:10.1016/j.neuroimage.2016.02.059. PMC   4970644 . PMID   26931816.
  31. ↑ Schwarb H, Johnson CL, Daugherty AM, Hillman CH, Kramer AF, Cohen NJ, Barbey AK (June 2017). "Aerobic fitness, hippocampal viscoelasticity, and relational memory performance". NeuroImage. 153: 179–188. doi:10.1016/j.neuroimage.2017.03.061. PMC   5637732 . PMID   28366763.
  32. ↑ Murphy MC, Huston J, Jack CR, Glaser KJ, Manduca A, Felmlee JP, Ehman RL (September 2011). "Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography". Journal of Magnetic Resonance Imaging. 34 (3): 494–8. doi:10.1002/jmri.22707. PMC   3217096 . PMID   21751286.
  33. ↑ Murphy MC, Jones DT, Jack CR, Glaser KJ, Senjem ML, Manduca A, et al. (2016). "Regional brain stiffness changes across the Alzheimer's disease spectrum". NeuroImage. Clinical. 10: 283–90. doi:10.1016/j.nicl.2015.12.007. PMC   4724025 . PMID   26900568.
  34. ↑ Streitberger KJ, Sack I, Krefting D, Pfüller C, Braun J, Paul F, Wuerfel J (2012). "Brain viscoelasticity alteration in chronic-progressive multiple sclerosis". PLOS ONE. 7 (1): e29888. Bibcode:2012PLoSO...729888S. doi: 10.1371/journal.pone.0029888 . PMC   3262797 . PMID   22276134.
  35. ↑ Sandroff BM, Johnson CL, Motl RW (January 2017). "Exercise training effects on memory and hippocampal viscoelasticity in multiple sclerosis: a novel application of magnetic resonance elastography". Neuroradiology. 59 (1): 61–67. doi:10.1007/s00234-016-1767-x. PMID   27889837. S2CID   9100607.
  36. ↑ Sack I, Beierbach B, Wuerfel J, Klatt D, Hamhaber U, Papazoglou S, et al. (July 2009). "The impact of aging and gender on brain viscoelasticity". NeuroImage. 46 (3): 652–7. doi:10.1016/j.neuroimage.2009.02.040. PMID   19281851. S2CID   4843107.
  37. ↑ Sack I, Streitberger KJ, Krefting D, Paul F, Braun J (2011). "The influence of physiological aging and atrophy on brain viscoelastic properties in humans". PLOS ONE. 6 (9): e23451. Bibcode:2011PLoSO...623451S. doi: 10.1371/journal.pone.0023451 . PMC   3171401 . PMID   21931599.
  38. ↑ Kalra P, Raterman B, Mo X, Kolipaka A (August 2019). "Magnetic resonance elastography of brain: Comparison between anisotropic and isotropic stiffness and its correlation to age". Magnetic Resonance in Medicine. 82 (2): 671–679. doi:10.1002/mrm.27757. PMC   6510588 . PMID   30957304.
  39. ↑ Johnson CL, Telzer EH (October 2018). "Magnetic resonance elastography for examining developmental changes in the mechanical properties of the brain". Developmental Cognitive Neuroscience. 33: 176–181. doi:10.1016/j.dcn.2017.08.010. PMC   5832528 . PMID   29239832.
  40. ↑ McIlvain G, Schwarb H, Cohen NJ, Telzer EH, Johnson CL (November 2018). "Mechanical properties of the in vivo adolescent human brain". Developmental Cognitive Neuroscience. 34: 27–33. doi:10.1016/j.dcn.2018.06.001. PMC   6289278 . PMID   29906788.
  41. ↑ Bridger H (17 April 2019). "Seeing brain activity in 'almost real time'". Harvard Gazette. Retrieved 2019-04-20.
  42. ↑ Rouvière O, Souchon R, Pagnoux G, Ménager JM, Chapelon JY (October 2011). "Magnetic resonance elastography of the kidneys: feasibility and reproducibility in young healthy adults". J Magn Reson Imaging. 34 (4): 880–6. doi:10.1002/jmri.22670. PMC   3176985 . PMID   21769970.
  43. ↑ Lee CU, Glockner JF, Glaser KJ, Yin M, Chen J, Kawashima A, Kim B, Kremers WK, Ehman RL, Gloor JM (July 2012). "MR elastography in renal transplant patients and correlation with renal allograft biopsy: a feasibility study". Acad Radiol. 19 (7): 834–41. doi:10.1016/j.acra.2012.03.003. PMC   3377786 . PMID   22503893.
  44. ↑ Bensamoun, Sabine F.; Robert, Ludovic; Leclerc, Gwladys E.; Debernard, Laëtitia; Charleux, Fabrice (July 2011). "Stiffness imaging of the kidney and adjacent abdominal tissues measured simultaneously using magnetic resonance elastography". Clinical Imaging. 35 (4): 284–287. doi:10.1016/j.clinimag.2010.07.009. ISSN   1873-4499. PMID   21724121.
  45. ↑ Low, Gavin; Owen, Nicola E.; Joubert, Ilse; Patterson, Andrew J.; Graves, Martin J.; Alexander, Graeme J. M.; Lomas, David J. (October 2015). "Magnetic resonance elastography in the detection of hepatorenal syndrome in patients with cirrhosis and ascites". European Radiology. 25 (10): 2851–2858. doi:10.1007/s00330-015-3723-2. ISSN   1432-1084. PMID   25903705. S2CID   1606666.
  46. ↑ Zhang, Jiong; Yu, Yuanmeng; Liu, Xiaoshuang; Tang, Xiong; Xu, Feng; Zhang, Mingchao; Xie, Guotong; Zhang, Longjiang; Li, Xiang; Liu, Zhi-Hong (March 2021). "Evaluation of Renal Fibrosis by Mapping Histology and Magnetic Resonance Imaging". Kidney Diseases (Basel, Switzerland). 7 (2): 131–142. doi:10.1159/000513332. ISSN   2296-9381. PMC   8010230 . PMID   33824869.
  47. ↑ Gandhi, Deep; Kalra, Prateek; Raterman, Brian; Mo, Xiaokui; Dong, Huiming; Kolipaka, Arunark (November 2019). "Magnetic Resonance Elastography of kidneys: SE-EPI MRE reproducibility and its comparison to GRE MRE". NMR in Biomedicine. 32 (11): e4141. doi:10.1002/nbm.4141. ISSN   1099-1492. PMC   6817380 . PMID   31329347.
  48. ↑ Low, Gavin; Owen, Nicola E.; Joubert, Ilse; Patterson, Andrew J.; Graves, Martin J.; Glaser, Kevin J.; Alexander, Graeme J. M.; Lomas, David J. (September 2015). "Reliability of magnetic resonance elastography using multislice two-dimensional spin-echo echo-planar imaging (SE-EPI) and three-dimensional inversion reconstruction for assessing renal stiffness". Journal of Magnetic Resonance Imaging. 42 (3): 844–850. doi:10.1002/jmri.24826. ISSN   1522-2586. PMC   4560097 . PMID   25537823.
  49. ↑ Marticorena Garcia, Stephan Rodrigo; Fischer, Thomas; Dürr, Michael; Gültekin, Emin; Braun, Jürgen; Sack, Ingolf; Guo, Jing (September 2016). "Multifrequency Magnetic Resonance Elastography for the Assessment of Renal Allograft Function". Investigative Radiology. 51 (9): 591–595. doi:10.1097/RLI.0000000000000271. ISSN   1536-0210. PMID   27504796. S2CID   34327744.
  50. ↑ Kim, J. K.; Yuen, D. A.; Leung, G.; Jothy, S.; Zaltzman, J.; Ramesh Prasad, G. V.; Prabhudesai, V.; Mnatzakanian, G.; Kirpalani, A. (September 2017). "Role of Magnetic Resonance Elastography as a Noninvasive Measurement Tool of Fibrosis in a Renal Allograft: A Case Report". Transplantation Proceedings. 49 (7): 1555–1559. doi:10.1016/j.transproceed.2017.04.002. ISSN   1873-2623. PMID   28838439.
  51. ↑ Kirpalani, Anish; Hashim, Eyesha; Leung, General; Kim, Jin K.; Krizova, Adriana; Jothy, Serge; Deeb, Maya; Jiang, Nan N.; Glick, Lauren; Mnatzakanian, Gevork; Yuen, Darren A. (2017-10-06). "Magnetic Resonance Elastography to Assess Fibrosis in Kidney Allografts". Clinical Journal of the American Society of Nephrology. 12 (10): 1671–1679. doi:10.2215/CJN.01830217. ISSN   1555-905X. PMC   5628708 . PMID   28855238.
  52. ↑ Marticorena Garcia, Stephan R.; Althoff, Christian E.; Dürr, Michael; Halleck, Fabian; Budde, Klemens; Grittner, Ulrike; Burkhardt, Christian; Jöhrens, Korinna; Braun, Jürgen; Fischer, Thomas; Hamm, Bernd (2021-02-01). "Tomoelastography for Longitudinal Monitoring of Viscoelasticity Changes in the Liver and in Renal Allografts after Direct-Acting Antiviral Treatment in 15 Kidney Transplant Recipients with Chronic HCV Infection". Journal of Clinical Medicine. 10 (3): 510. doi: 10.3390/jcm10030510 . ISSN   2077-0383. PMC   7867050 . PMID   33535495.
  53. ↑ Marticorena Garcia, Stephan Rodrigo; Grossmann, Markus; Bruns, Anne; Dürr, Michael; Tzschätzsch, Heiko; Hamm, Bernd; Braun, Jürgen; Sack, Ingolf; Guo, Jing (February 2019). "Tomoelastography Paired With T2* Magnetic Resonance Imaging Detects Lupus Nephritis With Normal Renal Function". Investigative Radiology. 54 (2): 89–97. doi:10.1097/RLI.0000000000000511. ISSN   1536-0210. PMID   30222647. S2CID   52286012.
  54. ↑ Lang, Sophia Theresa; Guo, Jing; Bruns, Anne; Dürr, Michael; Braun, Jürgen; Hamm, Bernd; Sack, Ingolf; Marticorena Garcia, Stephan Rodrigo (October 2019). "Multiparametric Quantitative MRI for the Detection of IgA Nephropathy Using Tomoelastography, DWI, and BOLD Imaging". Investigative Radiology. 54 (10): 669–674. doi:10.1097/RLI.0000000000000585. ISSN   1536-0210. PMID   31261295. S2CID   195772720.
  55. ↑ Brown, Robert S.; Sun, Maryellen R. M.; Stillman, Isaac E.; Russell, Teresa L.; Rosas, Sylvia E.; Wei, Jesse L. (2020-06-01). "The utility of magnetic resonance imaging for noninvasive evaluation of diabetic nephropathy". Nephrology, Dialysis, Transplantation. 35 (6): 970–978. doi:10.1093/ndt/gfz066. ISSN   1460-2385. PMC   7282829 . PMID   31329940.
  56. ↑ Prezzi, Davide; Neji, Radhouene; Kelly-Morland, Christian; Verma, Hema; OʼBrien, Tim; Challacombe, Ben; Fernando, Archana; Chandra, Ashish; Sinkus, Ralph; Goh, Vicky (June 2018). "Characterization of Small Renal Tumors With Magnetic Resonance Elastography: A Feasibility Study". Investigative Radiology. 53 (6): 344–351. doi:10.1097/RLI.0000000000000449. ISSN   1536-0210. PMID   29462024. S2CID   3435686.
  57. ↑ Han, Jun Hee; Ahn, Jhii-Hyun; Kim, Jae-Seok (December 2020). "Magnetic resonance elastography for evaluation of renal parenchyma in chronic kidney disease: a pilot study". La Radiologia Medica. 125 (12): 1209–1215. doi:10.1007/s11547-020-01210-1. ISSN   1826-6983. PMID   32367323. S2CID   218495236.
  58. 1 2 Güven, Alper Tuna; Idilman, Ilkay S.; Cebrayilov, Cebrayil; Önal, Ceren; Kibar, Müge Üzerk; Sağlam, Arzu; Yıldırım, Tolga; Yılmaz, Rahmi; Altun, Bülent; Erdem, Yunus; Karçaaltıncaba, Muşturay (January 2022). "Evaluation of renal fibrosis in various causes of glomerulonephritis by MR elastography: a clinicopathologic comparative analysis". Abdominal Radiology. 47 (1): 288–296. doi:10.1007/s00261-021-03296-1. ISSN   2366-0058. PMID   34633496. S2CID   238534093.
  59. ↑ Dittmann, Florian; Tzschätzsch, Heiko; Hirsch, Sebastian; Barnhill, Eric; Braun, Jürgen; Sack, Ingolf; Guo, Jing (September 2017). "Tomoelastography of the abdomen: Tissue mechanical properties of the liver, spleen, kidney, and pancreas from single MR elastography scans at different hydration states". Magnetic Resonance in Medicine. 78 (3): 976–983. doi: 10.1002/mrm.26484 . ISSN   1522-2594. PMID   27699875. S2CID   33374176.
  60. ↑ Marticorena Garcia, Stephan Rodrigo; Grossmann, Markus; Lang, Sophia Theresa; Tzschätzsch, Heiko; Dittmann, Florian; Hamm, Bernd; Braun, Jürgen; Guo, Jing; Sack, Ingolf (April 2018). "Tomoelastography of the native kidney: Regional variation and physiological effects on in vivo renal stiffness". Magnetic Resonance in Medicine. 79 (4): 2126–2134. doi:10.1002/mrm.26892. ISSN   1522-2594. PMID   28856718. S2CID   25438749.
  61. ↑ Kemper J, Sinkus R, Lorenzen J, Nolte-Ernsting C, Stork A, Adam G (August 2004). "MR elastography of the prostate: initial in-vivo application". RöFo. 176 (8): 1094–9. doi:10.1055/s-2004-813279. PMID   15346284. S2CID   260312137.
  62. ↑ Sahebjavaher RS, Frew S, Bylinskii A, ter Beek L, Garteiser P, Honarvar M, Sinkus R, Salcudean S (July 2014). "Prostate MR elastography with transperineal electromagnetic actuation and a fast fractionally encoded steady-state gradient echo sequence". NMR Biomed. 27 (7): 784–94. doi:10.1002/nbm.3118. PMID   24764278. S2CID   10640155.
  63. ↑ Arani A, Da Rosa M, Ramsay E, Plewes DB, Haider MA, Chopra R (November 2013). "Incorporating endorectal MR elastography into multi-parametric MRI for prostate cancer imaging: Initial feasibility in volunteers". J Magn Reson Imaging. 38 (5): 1251–60. doi: 10.1002/jmri.24028 . PMID   23408516.
  64. ↑ Sahebjavaher RS, Nir G, Honarvar M, Gagnon LO, Ischia J, Jones EC, Chang SD, Fazli L, Goldenberg SL, Rohling R, Kozlowski P, Sinkus R, Salcudean SE (January 2015). "MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods". NMR Biomed. 28 (1): 124–39. doi:10.1002/nbm.3218. PMID   25395244. S2CID   206307554.
  65. ↑ Asbach P, Ro SR, Aldoj N, Snellings J, Reiter R, Lenk J, Köhlitz T, Haas M, Guo J, Hamm B, Braun J, Sack I (August 2020). "In Vivo Quantification of Water Diffusion, Stiffness, and Tissue Fluidity in Benign Prostatic Hyperplasia and Prostate Cancer". Invest Radiol. 55 (8): 524–530. doi:10.1097/RLI.0000000000000685. PMID   32496317. S2CID   219315386.
  66. 1 2 Li M, Guo J, Hu P, Jiang H, Chen J, Hu J, Asbach P, Sack I, Li W (2021). "Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI". Radiology. 299 (2): 362–370. doi:10.1148/radiol.2021201852. PMID   33687285. S2CID   232161536.
  67. ↑ Hectors SJ, Lewis S (March 2021). "Tomoelastography of the Prostate: Use of Tissue Stiffness for Improved Cancer Detection". Radiology. 299 (2): 371–373. doi:10.1148/radiol.2021210292. PMID   33689473. S2CID   232195893.
  68. ↑ (Serai SD, Abu-El-Haija M, Trout AT (May 2019). "3D MR elastography of the pancreas in children". Abdom Radiol (NY). 44 (5): 1834–1840. doi:10.1007/s00261-019-01903-w. PMC   8579322 . PMID   30683979. S2CID   59259395.
  69. ↑ Shi Y, Gao F, Li Y, Tao S, Yu B, Liu Z, Liu Y, Glaser KJ, Ehman RL, Guo Q (March 2018). "Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction: a prospective study". Eur Radiol. 28 (3): 936–945. doi:10.1007/s00330-017-5062-y. PMC   5812826 . PMID   28986646.
  70. ↑ Shi Y, Liu Y, Gao F, Liu Y, Tao S, Li Y, Glaser KJ, Ehman RL, Guo Q (August 2018). "Pancreatic Stiffness Quantified with MR Elastography: Relationship to Postoperative Pancreatic Fistula after Pancreaticoenteric Anastomosis". Radiology. 288 (2): 476–484. doi:10.1148/radiol.2018170450. PMC   6067817 . PMID   29664337.
  71. ↑ Marticorena Garcia SR, Zhu L, Gültekin E, Schmuck R, Burkhardt C, Bahra M, Geisel D, Shahryari M, Braun J, Hamm B, Jin ZY, Sack I, Guo J (December 2020). "Tomoelastography for Measurement of Tumor Volume Related to Tissue Stiffness in Pancreatic Ductal Adenocarcinomas". Invest Radiol. 55 (12): 769–774. doi:10.1097/RLI.0000000000000704. PMID   32796197. S2CID   221133340.
  72. ↑ Zhu L, Guo J, Jin Z, Xue H, Dai M, Zhang W, Sun Z, Xu J, Marticorena Garcia SR, Asbach P, Hamm B, Sack I (October 2020). "Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography". Eur Radiol. 31 (5): 3366–3374. doi:10.1007/s00330-020-07420-5. PMID   33125553. S2CID   225994738.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.